ES2001752A6 - Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente. - Google Patents
Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente.Info
- Publication number
- ES2001752A6 ES2001752A6 ES8600629A ES8600629A ES2001752A6 ES 2001752 A6 ES2001752 A6 ES 2001752A6 ES 8600629 A ES8600629 A ES 8600629A ES 8600629 A ES8600629 A ES 8600629A ES 2001752 A6 ES2001752 A6 ES 2001752A6
- Authority
- ES
- Spain
- Prior art keywords
- virus
- animals
- vaccine
- wild
- deletion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000700605 Viruses Species 0.000 title abstract 11
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 abstract 5
- 230000037430 deletion Effects 0.000 abstract 2
- 238000012217 deletion Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 abstract 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 229940124841 Herpesvirus vaccine Drugs 0.000 abstract 1
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 230000000405 serological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
Abstract
EL INVENTO SE REFIERE A UN PROCEDIMIENTO PARA PRODUCIR UNA VACUNA DE HERPESVIRUS Y PARA PRODUCIR UNA VACUNA MULTIVALENTE, CONSISTENTE EN REALIZAR LA INCAPACITACION APROPIADA DE UN VIRUS SUPRIMIENDO UN GEN CODIFICANDO UNA GLICOPROTEINA Y SEGUN OTRA VARIANTE DEL PROCEDIMIENTO Y CON EL FIN DE OBTENER UNA VACUNA MULTIVALENTE SE EFECTUA LA INCAPACITACION APROPIADA DE UN VIRUS, TENIENDO INSERTO, DENTRO DE UN GEN CODIFICANDO UN ANTIGENO, UNA SECUENCIA DE DNA, CODIFICANDO UN POLIPEPTIDO HETEROLOGO, CAPAZ DE AUMENTAR UNA RESPUESTA INMUNE.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES8600629A ES2001752A6 (es) | 1985-07-29 | 1986-07-28 | Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76013085A | 1985-07-29 | 1985-07-29 | |
ES8600629A ES2001752A6 (es) | 1985-07-29 | 1986-07-28 | Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2001752A6 true ES2001752A6 (es) | 1988-06-16 |
Family
ID=25058182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES8600629A Expired ES2001752A6 (es) | 1985-07-29 | 1986-07-28 | Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4810634A (es) |
EP (1) | EP0231209B1 (es) |
JP (2) | JP2559384B2 (es) |
KR (1) | KR950000887B1 (es) |
CN (1) | CN1018845B (es) |
AT (1) | ATE60799T1 (es) |
AU (1) | AU591145B2 (es) |
CA (1) | CA1275625C (es) |
DE (1) | DE3677494D1 (es) |
DK (1) | DK170948B1 (es) |
ES (1) | ES2001752A6 (es) |
FI (1) | FI871362A0 (es) |
HK (1) | HK32696A (es) |
IE (1) | IE59087B1 (es) |
NO (1) | NO301284B1 (es) |
PH (1) | PH25776A (es) |
WO (1) | WO1987000862A1 (es) |
ZA (1) | ZA865277B (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041536A (en) * | 1984-05-02 | 1991-08-20 | The Upjohn Company | Pseudorabies virus (PRV) gene |
US5128128A (en) * | 1985-07-29 | 1992-07-07 | The Upjohn Company | Virus vaccine |
US5275934A (en) * | 1985-07-29 | 1994-01-04 | The Upjohn Company | Method of detecting viral infection in vaccinated animals |
EP0263207B1 (en) * | 1986-10-08 | 1991-11-27 | The Upjohn Company | Virus vaccine |
US5047237A (en) * | 1985-09-06 | 1991-09-10 | Prutech Research And Development Partnership | Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
US5068192A (en) * | 1986-01-27 | 1991-11-26 | Prutech Research And Development Partnership | Attenuated pseudorabies virus which includes foreign DNA encoding an amino acid sequence |
US5763269A (en) * | 1985-09-06 | 1998-06-09 | Syntro Corporation | Recombinant infectious bovine rhinotrocheitis virus |
AU601378B2 (en) * | 1985-10-04 | 1990-09-13 | Pharmacia & Upjohn Company | Pseudorabies virus protein |
US5352575A (en) * | 1985-10-04 | 1994-10-04 | The Upjohn Company | Pseudorabies virus protein |
WO1987004463A1 (en) * | 1986-01-27 | 1987-07-30 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
US5593873A (en) * | 1986-01-27 | 1997-01-14 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
US6172186B1 (en) | 1986-03-26 | 2001-01-09 | Pharmacia & Upjohn Company | Pseudorabies virus protein |
FR2601689B1 (fr) * | 1986-07-17 | 1992-10-16 | Syntro Corp | Herpes virus attenues, herpes virus qui renferment de l'adn etranger codant pour une sequence d'amino-acides, et vaccins les contenant |
US5037742A (en) * | 1986-07-18 | 1991-08-06 | E. I. Du Pont De Nemours And Company | Pseudorabies virus recombinants and their use in the production of proteins |
US5004693A (en) * | 1986-07-18 | 1991-04-02 | E. I. Du Pont De Nemours And Company | Pseudorabies virus recombinants and their use in the production of proteins |
WO1988007088A1 (en) * | 1987-03-19 | 1988-09-22 | Synergen, Inc. | Viral vector system for the introduction of foreign dna expression products into gallinaceous birds |
US5273876A (en) * | 1987-06-26 | 1993-12-28 | Syntro Corporation | Recombinant human cytomegalovirus containing foreign gene |
US5783195A (en) * | 1991-07-18 | 1998-07-21 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof |
WO1989001040A1 (en) * | 1987-07-27 | 1989-02-09 | Syntro Corporation | Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
US4992051A (en) * | 1987-11-03 | 1991-02-12 | Novagene, Inc. | Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same |
US5128129A (en) * | 1987-11-03 | 1992-07-07 | Novagene Inc. | Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
US5069901A (en) * | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
JP2779447B2 (ja) * | 1988-03-20 | 1998-07-23 | 財団法人阪大微生物病研究会 | 弱毒マレック病ウイルス・ベクターを用いる組換え遺伝子作成法、及び該ウイルスの組換え体 |
JP2583115B2 (ja) * | 1988-09-10 | 1997-02-19 | 財団法人化学及血清療法研究所 | 組換えマレック病ウイルスおよびその製法 |
US5122447A (en) * | 1989-01-23 | 1992-06-16 | Iowa State University Research Foundation, Inc. | Method of detecting pseudorabies virus specific serum antibody by use of a universal diagnostic antigen |
US5240703A (en) * | 1991-03-01 | 1993-08-31 | Syntro Corporation | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
US5874279A (en) * | 1991-07-18 | 1999-02-23 | Syntro Corporation | Recombinant infectious bovine rhinotracheitis virus |
CA2113641A1 (en) * | 1991-07-18 | 1993-02-04 | Mark D. Cochran | Recombinant infectious bovine rhinotracheitis virus |
WO1993024147A1 (en) * | 1992-05-29 | 1993-12-09 | Smithkline Beecham Corporation | Lecithin adjuvanted modified live virus vaccines |
TW289731B (es) * | 1992-07-09 | 1996-11-01 | Akzo Nv | |
EP0606452B1 (en) * | 1992-07-30 | 2002-11-13 | Akzo Nobel N.V. | Vector vaccines of recombinant feline herpesvirus |
WO1994008000A1 (en) * | 1992-10-06 | 1994-04-14 | Akzo Nobel N.V. | Pseudorabies virus vaccine |
US5738854A (en) * | 1992-10-06 | 1998-04-14 | Akzo Nobel N.V. | Pseudorabies virus vaccine |
ES2074965B1 (es) * | 1994-01-31 | 1996-05-01 | Hipra Lab Sa | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. |
WO1995035380A1 (en) * | 1994-06-17 | 1995-12-28 | Instituut Voor Dierhouderij En Diergezondheid | Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
US6284251B1 (en) | 1996-02-26 | 2001-09-04 | Kansas State University Research Foundation | BHV-1 gene-deleted virus vaccine |
GB0126047D0 (en) * | 2001-10-30 | 2001-12-19 | Univ Cambridge Tech | Therapeutic molecules |
CN106456805B (zh) | 2014-03-03 | 2020-01-10 | 阿尔伯特爱因斯坦医学院公司 | 重组单纯疱疹病毒2(hsv-2)疫苗载体 |
US10918712B2 (en) | 2014-03-03 | 2021-02-16 | Albert Einstein College Of Medicine | Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors |
WO2017106736A1 (en) * | 2015-12-18 | 2017-06-22 | Louisiana State University Research & Technology Foundation | Pseudorabies virus (prv) vector expressing heterologous polypeptides |
KR20210088655A (ko) * | 2018-11-06 | 2021-07-14 | 베링거잉겔하임베트메디카게엠베하 | 조류 인플루엔자 바이러스 h5 서브타입에 대한 면역원성 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
NL8303501A (nl) * | 1983-10-12 | 1985-05-01 | Centraal Diergeneeskundig Inst | Deletiemutant van een herpesvirus en vaccin, dat dit virus bevat. |
US4514497B1 (en) * | 1983-12-30 | 1998-02-24 | Novagene Inc | Modified live pseudorabies viruses |
US4703011A (en) * | 1985-11-12 | 1987-10-27 | Novagene, Inc. | Thymidine kinase deletion mutants of bovine herpesvirus-1 |
US4711850A (en) * | 1986-01-28 | 1987-12-08 | Novagene, Inc. | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
-
1986
- 1986-06-17 DE DE8686904022T patent/DE3677494D1/de not_active Expired - Lifetime
- 1986-06-17 US US07/049,865 patent/US4810634A/en not_active Expired - Lifetime
- 1986-06-17 AU AU59948/86A patent/AU591145B2/en not_active Expired
- 1986-06-17 EP EP86904022A patent/EP0231209B1/en not_active Expired - Lifetime
- 1986-06-17 WO PCT/US1986/001322 patent/WO1987000862A1/en active IP Right Grant
- 1986-06-17 JP JP61503474A patent/JP2559384B2/ja not_active Expired - Lifetime
- 1986-06-17 KR KR1019870700280A patent/KR950000887B1/ko not_active IP Right Cessation
- 1986-06-17 AT AT86904022T patent/ATE60799T1/de not_active IP Right Cessation
- 1986-07-11 CA CA000513617A patent/CA1275625C/en not_active Expired - Lifetime
- 1986-07-15 ZA ZA865277A patent/ZA865277B/xx unknown
- 1986-07-23 PH PH34058A patent/PH25776A/en unknown
- 1986-07-28 ES ES8600629A patent/ES2001752A6/es not_active Expired
- 1986-07-28 IE IE199686A patent/IE59087B1/en not_active IP Right Cessation
- 1986-07-29 CN CN86105450A patent/CN1018845B/zh not_active Expired
-
1987
- 1987-03-27 FI FI871362A patent/FI871362A0/fi not_active Application Discontinuation
- 1987-03-27 DK DK157087A patent/DK170948B1/da active IP Right Grant
- 1987-03-27 NO NO871313A patent/NO301284B1/no not_active IP Right Cessation
-
1995
- 1995-12-18 JP JP7328734A patent/JP2738524B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-22 HK HK32696A patent/HK32696A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU5994886A (en) | 1987-03-05 |
US4810634A (en) | 1989-03-07 |
ATE60799T1 (de) | 1991-02-15 |
HK32696A (en) | 1996-03-01 |
NO871313L (no) | 1987-03-27 |
CA1275625C (en) | 1990-10-30 |
DK170948B1 (da) | 1996-03-25 |
EP0231209B1 (en) | 1991-02-06 |
DK157087D0 (da) | 1987-03-27 |
DE3677494D1 (de) | 1991-03-14 |
CN1018845B (zh) | 1992-10-28 |
JPH08333279A (ja) | 1996-12-17 |
FI871362A (fi) | 1987-03-27 |
AU591145B2 (en) | 1989-11-30 |
WO1987000862A1 (en) | 1987-02-12 |
JP2559384B2 (ja) | 1996-12-04 |
PH25776A (en) | 1991-10-18 |
JP2738524B2 (ja) | 1998-04-08 |
KR950000887B1 (ko) | 1995-02-03 |
IE861996L (en) | 1987-01-29 |
KR880700070A (ko) | 1988-02-15 |
DK157087A (da) | 1987-03-27 |
EP0231209A1 (en) | 1987-08-12 |
CN86105450A (zh) | 1987-03-04 |
FI871362A0 (fi) | 1987-03-27 |
IE59087B1 (en) | 1994-01-12 |
NO871313D0 (no) | 1987-03-27 |
NO301284B1 (no) | 1997-10-06 |
ZA865277B (en) | 1987-03-25 |
JPS63500449A (ja) | 1988-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA865277B (en) | Virus vaccine | |
CA2031164A1 (en) | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof | |
HUT69803A (en) | Porcine reproductive respiratory syndrome vaccine and diagnostic | |
DE3786824D1 (de) | Rekombinante herpes simplex-viren, vakzine und verfahren. | |
DE69225471D1 (de) | Abgeschwächtes, gentechnologisch hergestelltes pseudorabies virus s-prv-155 und seine verwendungen | |
UA40571C2 (uk) | Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена | |
EP0232798A3 (en) | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
DE69332264D1 (de) | Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe | |
CA2012414A1 (en) | Hog cholera virus vaccine and diagnostic | |
GR3007856T3 (es) | ||
DE69333730D1 (de) | Impfstoff, der acemannan als adjuvans enthält | |
DE122007000004I1 (de) | Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, unddiese enthaltende Impfstoffe | |
ZA923041B (en) | Recombinant vaccine against marek's disease | |
EP0496787A4 (en) | Novel infectious bursal disease virus | |
ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
GR861842B (en) | Infectious bronchitis vaccines for a day-old chickens | |
Joklik | Antigenic relationships between the proteins of the three serotypes of reovirus. | |
O'Callaghan | Vaccine against equine herpesvirus type 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1A | Transfer granted | ||
FD1A | Patent lapsed |
Effective date: 20060729 |